These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
515 related items for PubMed ID: 15265968
21. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy. Smith CJ, Sabin CA, Youle MS, Kinloch-de Loes S, Lampe FC, Madge S, Cropley I, Johnson MA, Phillips AN. J Infect Dis; 2004 Nov 15; 190(10):1860-8. PubMed ID: 15499544 [Abstract] [Full Text] [Related]
22. Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Massad LS, Silverberg MJ, Springer G, Minkoff H, Hessol N, Palefsky JM, Strickler HD, Levine AM, Sacks HS, Moxley M, Heather Watts D. Am J Obstet Gynecol; 2004 May 15; 190(5):1241-8. PubMed ID: 15167825 [Abstract] [Full Text] [Related]
25. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Ylitalo N, Josefsson A, Melbye M, Sörensen P, Frisch M, Andersen PK, Sparén P, Gustafsson M, Magnusson P, Pontén J, Gyllensten U, Adami HO. Cancer Res; 2000 Nov 01; 60(21):6027-32. PubMed ID: 11085523 [Abstract] [Full Text] [Related]
27. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Heard I, Palefsky JM, Kazatchkine MD. Antivir Ther; 2004 Feb 01; 9(1):13-22. PubMed ID: 15040532 [Abstract] [Full Text] [Related]
33. Cervical screening in HIV-positive women: characteristics of those who default and attitudes towards screening. Shah S, Montgomery H, Smith C, Madge S, Walker P, Evans H, Johnson M, Sabin C. HIV Med; 2006 Jan 01; 7(1):46-52. PubMed ID: 16313292 [Abstract] [Full Text] [Related]
37. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study. McDermott AY, Terrin N, Wanke C, Skinner S, Tchetgen E, Shevitz AH. Clin Infect Dis; 2005 Dec 01; 41(11):1662-70. PubMed ID: 16267741 [Abstract] [Full Text] [Related]
39. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up. Resino S, Resino R, Micheloud D, Gurbindo Gutiérrez D, Léon JA, Ramos JT, Ciria L, de José I, Mellado J, Muñoz-Fernández A, Spanish Group of Paediatric HIV Infection. Clin Infect Dis; 2006 Mar 15; 42(6):862-9. PubMed ID: 16477566 [Abstract] [Full Text] [Related]
40. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City. Ramírez-Amador V, Ponce-de-León S, Anaya-Saavedra G, Crabtree Ramírez B, Sierra-Madero J. Clin Infect Dis; 2007 Oct 01; 45(7):925-32. PubMed ID: 17806063 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]